Article Information
History
- January 4, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicholas F.G. Chen1,
- Kien Pham1,
- Chrispin Chaguza1,2,
- Rafael Lopes1,2,
- Fayette Klaassen3,
- Daniel M. Weinberger1,2,
- Virginia E. Pitzer1,2,
- Joshua L. Warren2,4,
- Nathan D. Grubaugh1,2,5,* and
- Anne M. Hahn1,*,#
- 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, United States,
- 2Public Health Modeling Unit, Yale School of Public Health, New Haven, United States,
- 3Department of Global Health & Population, Harvard T. H. Chan School of Public Health, Boston, United States,
- 4Department of Biostatistics, Yale School of Public Health, New Haven, United States
- 5Department of Ecology and Evolutionary Biology, Yale University, New Haven, United States
- ↵#corresponding author: anne.hahn{at}yale.edu
↵* These authors contributed equally to this work.
Posted January 04, 2024.
Escalating combinations of enhanced infectivity and immune escape define SARS-CoV-2 Omicron lineage replacement
